Hostname: page-component-76d6cb85b7-92wsb Total loading time: 0 Render date: 2026-07-16T13:01:45.909Z Has data issue: false hasContentIssue false

Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach

Published online by Cambridge University Press:  23 May 2025

A response to the following question: How can we improve and facilitate multi-sectoral collaboration in warning and response systems for infectious diseases and natural hazards to account for their drivers, interdependencies and cascading impacts?

Victoria A. Osasah*
Affiliation:
Department of Environmental Health & Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA Johns Hopkins Center for Health Security, 700 East Pratt Street Suite 900, Baltimore, MD, 21202, USA
Eri Togami
Affiliation:
Department of Environmental Health & Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
Mehdi Aloosh
Affiliation:
Department of Health Research Methods, Evidence, and Impact, McMaster University, Suite 2006 100 Main St. West, Hamilton, ON, L8P 1H6, Canada
Monica Schoch-Spana
Affiliation:
Department of Environmental Health & Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA Johns Hopkins Center for Health Security, 700 East Pratt Street Suite 900, Baltimore, MD, 21202, USA
Meghan F. Davis
Affiliation:
Department of Environmental Health & Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA Department of Molecular & Comparative Pathobiology & Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
*
Corresponding author: Victoria A. Osasah; Email: vosasah1@jh.edu
Rights & Permissions [Opens in a new window]

Abstract

Recent increases in dengue cases across the region of the Americas have underscored the need for an integrated and collaborative One Health approach to address the potential of widespread autochthonous dengue in the continental USA. Improvements in the public health, social and health sectors are paramount in ensuring that communities are better protected. Furthermore, communities would benefit from effective adaptive strategies in the event of autochthonous dengue outbreaks. There is an opportunity to address existing challenges in the control of mosquitoes, public health infrastructure and funding that are necessary to recover from threats from climate-sensitive pathogens. Each component will improve preparedness toward widespread autochthonous dengue. This review provides an outline of adaptive and mitigating strategies and offers opportunities to address challenges through a One Health lens.

Information

Type
Impact Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1. Factors linked to a community’s vulnerability to dengue.

Author Comment: Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach — R0/PR1

Comments

No accompanying comment.

Review: Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach — R0/PR2

Comments

This manuscript brings up some key issues and topics relevant to mosquito control and building a responsive and inclusive public health plan to manage mosquito-borne disease. Please see below for some specific comments, corrections, and recommendations to improve the manuscript.

Lines 33-38- Hawaii does not have widespread autochthonous dengue transmission. The last outbreak in 2015 was ~260 cases and limited to a small are of one part of one island. Prior to that the case numbers were on par with the outbreaks noted earlier in the paragraph in Florida in limited locations on one island and are much less frequent than occur in Florida. Sangwoo et al. 2022 Frontiers in Tropical Diseases reviews this information. As indicated Puerto Rico fits this description, but so do other US territories. The Sangwoo et al. 2022 article will have some information about those too, but the CDC website should as well.

Lines 83-87- While this paragraph is tempered with some “could” and “may” a sentence or two could probably be included that encapsulate that many of these nuisance mosquitoes are also potential vectors, and sometimes displaced native, typically non-human biting mosquitoes that served a similar ecological role as pollinators, prey etc. For example, when Aedes albopictus arrived in Florida it displaced many native mosquitoes, Aedes triseriatus, Wyeomyia mitchellii, Orthopodomyia signifera and many others. A great overview of this was published in 2021 by Phil Lounibos as an IFAS extension doc, ENY2057. Most of these species rarely bite humans/transmit disease and still exist in small populations in Florida, or in nearby states and could potentially refill these niches if Aedes albopictus was eradicated.

Line 104- Albopictus should be lowercase

Line 105- not sure that canola oil is necessarily “non-toxic” in the context of mosquito control. When used as a mosquito larval control, canola oil/other oils work by suffocating/drowning mosquito larvae that need to obtain oxygen at the water’s surface. This killing is not limited to mosquitoes and any aquatic organism that obtains oxygen in a similar manner will be killed and some that land on the water surface and get stuck in the oil will also drown. Bacillus thuringiensis (Bti) might be a better example as it is non-toxic to almost anything that isn’t a mosquito or fly, and is even sold for home use. The National Pesticide Information Center will have more information.

Line 108- I don’t really think that this paragraph illuminates the “Challenges with core capacities for mosquito surveillance and control” header. Some suggestions: Line 109- any takeaways or specifics on the improvements LCVPs noted. Line 110: What gaps in capacity? Line 111: What is the existing funding structure, earlier paragraphs indicate that “legal authority responsible for mosquito control varies across states”, so I am assuming funding does as well. So, with these inconsistencies does changing the existing funding structure really work as a blanket statement. Possibly so, but we don’t have enough background to evaluate.

Line 118 even with proper insecticide resistance testing you can get extensive insecticide resistance in the populations, because alternative insecticide options are limited and often expensive. So, many programs have nothing to switch to even if they do test for resistance.

Line 123- standard phrasing is “decreased sensitivity”

Dissemination as written could also be confusing for audiences outside of the vector biology/vector control space, as it means something different outside of these fields. Perhaps rephrase to “correlated with dengue susceptibility”.

Line 126- Would not bring up the metagenome here unless you discuss or reference the mosquito microbiota and insecticide resistance above. Otherwise, this is out of place.

Line 128- A couple of really important points are missing here. 1) chemical mosquito control is not species-specific. It kills everything, including things we want and need, like bees. Wolbachia and genetically engineered mosquito technologies are species specific and do not kill non-target organisms. This species-specificity is a huge benefit for this approach and incredibly so from a one-health standpoint. Chemicals indiscriminately kill lots of non-target organisms and potentially build up in the environment, accumulate in animals, etc.. Wolbachia and genetically engineered approaches (at least the ones tested in the field for mosquito control to date, such as sterile insect technique (SIT- genetically modified by radiation, or a new CRISPR-based SIT, such as the precision-guided SIT- not tested in the field for mosquito control (Aedes mosquitoes- Li et al 2021 Nature Communications; Li et al 2023 eLife) but it has been built in mosquitoes and trials have been done for agricultural pests or RIDL (Release of insects carrying a dominant lethal) do not. 2) Wolbachia (World Mosquito Program), SIT (IAEA) and RIDL (Oxitec) are all non-chemical technologies that have been tested in the field for Aedes aegypti/dengue control and should all be included here, since they have become parts of mosquito control efforts. Wolbachia is not genetically modified (see comments below), but the SIT and RIDL are genetically modified (SIT randomly modified by radiation, and RIDL engineered in the lab). 3) What other similar technologies are in development for mosquito control? Maybe mention technologies in the pipeline for field release and would have a one-health oriented benefit. For example, the precision guided-SIT is an SIT technology that uses CRISPR to sterilize male mosquitoes instead of radiation, so programs don’t need to use ionizing radiation to sterilize mosquitoes. These 3 points do not have to be discussed at length, but all should be mentioned and addressed.

Line 130- Wolbachia is not genetically modified. It does not change the mosquito genome. It is a naturally occurring bacteria that in the context of mosquito control are introduced to mosquito species to impact mosquito reproduction and possibly their ability to transmit pathogens.

Line 132- due to the emphasis on Aedes and discussion of some of its pathogens, I would not be so general here. Include the mosquito species and the arboviruses. These specifics are included elsewhere and are relevant here.

Line 144- drainage of standing water in marshes is environmentally devasting, so we essentially do not do it anymore. It also would have no impact on Aedes aegypti, which appears to be the primary focus on this article. Aedes aegypti larvae do not live in marsh environments.

Line 186- the AcTs model acronym should be spelled out for clarity (Citizen Action through Science)

Lines 186-188 Do you have any other examples? University Park, MD was where this study was conducted has a much higher-than-average income and education level. The beginning of this paragraph emphasizes “diverse sociopolitical circumstances”. This example is not that, or at least should be noted as contrary to this.

Lines 189 – 200- This would benefit from the inclusion of some mosquito control topic specific examples. For example, increasing engagement from the Spanish speaking community on genetically engineered mosquito technologies (Cheung et al. 2020 Global Public Health), but other examples exist.

Decision: Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach — R0/PR3

Comments

This decision is based on a balanced review and careful consideration from the handling editor

Author Comment: Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach — R1/PR4

Comments

No accompanying comment.

Decision: Existing strategies to address the risk of mosquito-transmitted dengue in the continental USA: opportunities to adopt a One Health approach — R1/PR5

Comments

No accompanying comment.